Category Archives: TB

Research to combat dual epidemics: A conversation with CDC’s Jordan Tappero

By on .

Science Speaks is delving into the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a series of interviews with staffers who are key to the success of their programs. For the fourth interview in the series, we spoke with Jordan W. Tappero, MD, MPH, who […]

Lives in the Balance: MSF report exposes threat of HIV and TB in Myanmar

By on .

Nine-year-old Phoe Lone was diagnosed with HIV at the age of two, after both his parents passed away and he became increasingly ill.  He began receiving life-saving antiretroviral therapy (ART) one year later, one of the 23,000 people living with HIV in Myanmar who receive treatment from Medicins Sans Frontieres (MSF).  Today, he is healthy. […]

Online panel discusses management of second-line anti-TB drugs

By on .

The following is a guest blog post by Sophie Beauvais of The Global Health Delivery Project at Harvard University. Her post discusses the virtual panel discussion they are hosting this week on second-line anti-TB drug management with Dr. Lucica Ditiu from the Stop TB Partnership and several World Health Organization (WHO) experts. In the fight […]

Innovative programming to combat HIV, TB and cholera: A conversation with CDC’s John Vertefeuille

By on .

In this third post in a series of conversations with officials at the U.S. Centers for Disease Control and Prevention (CDC) discussing the CDC’s role in global HIV and tuberculosis research and development, Science Speaks sat down with John Vertefeuille, PhD – the country director for CDC in Haiti. There he leads a team of 55 and […]

CDC at the frontlines of TB research in Kenya: a conversation with Kayla Laserson

By on .

This is the first in a series of conversations with officials at the Centers for Disease Control and Prevention (CDC), discussing the CDC’s role in global HIV and tuberculosis research and development.  The following interview is with Kayla Laserson, Director of the Kenya Medical Research Institute (KEMRI)/CDC Field Research Station in Kisumu, Kenya. Dr. Laserson […]

NIH launches program to ease access to technologies for humanitarian efforts

By on .

At a White House briefing Wednesday morning on science, technology and innovation for global development, head of the National Institutes of Health (NIH) Dr. Francis Collins announced a new effort to increase access to innovative technologies for those working to provide broad global access to technologies, products and services…

HIV docs tell a powerful tale of combination prevention

By on .

“This is an extraordinary moment in the AIDS epidemic – we finally have the tools to turn the tide,” said Diane Havlir, MD, of the University of California San Francisco, speaking to the arsenal of HIV prevention interventions the AIDS community now has at its disposal to combat new infections worldwide. She spoke alongside a […]

Inaccurate TB blood tests commonplace in many TB high-burden countries

By on .

Although recent press attention has highlighted the problematic use of TB serological tests by medical providers in India, a new paper in The European Respiratory Journal (Widespread use of serological tests for tuberculosis: data from 22 high-burden countries) demonstrates that the use of these tests is much wider spread. Drs. J. Grenier and M. Pai conducted […]

NIAID announces funding ops for HIV Clinical Trial Networks, including TB and Hepatitis

By on .

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) and the leading funder of AIDS research, issued long-awaited funding announcements to create leadership groups for clinical research networks in HIV that will also address tuberculosis (TB) and hepatitis—leading co-morbidities in persons with HIV infection. Requests for applications […]